Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido - Contacts and Locations

Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido

This study is ongoing, but not recruiting participants.

Study NCT00566384. Last updated on October 30, 2008. Information provided by Bayer

Please refer to this study by its ClinicalTrials.gov identifier: NCT00566384

Locations


Germany

	Berlin, Germany, 10179

	Berlin, Germany, 14163

Germany, Berlin / 285

	Berlin, Berlin / 285, Germany, 10115

	Berlin, Berlin / 285, Germany, 13357

	Berlin, Berlin / 285, Germany, 10709

	Berlin, Berlin / 285, Germany, 10247

	Berlin, Berlin / 285, Germany, 13086

	Berlin, Berlin / 285, Germany, 13342

	Berlin, Berlin / 285, Germany, 10627

	Berlin, Berlin / 285, Germany, 10629

	Berlin, Berlin / 285, Germany, 14195

	Berlin, Berlin / 285, Germany, 12435

Germany, Hamburg / 287

	Hamburg, Hamburg / 287, Germany, 22143

Sponsors and Collaborators

Bayer

Investigators


Study Director:	Bayer Study Director	Bayer